Skip to content

Prospective randomized multicenter trial of prevention of groin complications by insertion of internal inguino-peritoneal drains after radical inguinofemoral lymphonodectomy for advanced vulvar cancer.

Prospective randomized multicenter trial of prevention of groin complications by insertion of internal inguino-peritoneal drains after radical inguinofemoral lymphonodectomy for advanced vulvar cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027334
Enrollment
100
Registered
2023-09-05
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C51

Interventions

Group 1: inguino-peritoneal drain Group 2: volume-controlled drain

Sponsors

Universitätsklinikum Augsburg
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age over 18 years - Inguinal-nodal positive vulvar carcinoma confirmed by sentinel lymphonodectomy (also after pos. frozen section) or by punch biopsy with indication for radical inguinofemoral lymphonodectomy unilaterally or bilaterally - Primary vulvar carcinoma with a stage T2(>4cm) Nx - Karnofsky index >80% and/or ECOG 0-1 - No history of invasive vulvar malignancy - Consent to adjuvant radiation if indicated postoperatively

Exclusion criteria

Exclusion criteria: - History of other malignancy with need for systematic therapy or radiotherapy in the vulva or groin area - Lack of compliance for groin compression (e.g., dementia) - Adipositas permagna from BMI 35 kg/m2

Design outcomes

Primary

MeasureTime frame
Reduction in the incidence of at least one postoperative complication such as seromas, lymphoceles, wound healing disorders, infections, or complications from drainage of severity greater than or equal to Clavien Dindo grade IIIa within 3 months after primary surgery. between patients with inguino-peritoneal drainage and volume-controlled drainage.

Secondary

MeasureTime frame
- Improvement in quality of life - Shortening of time to start of adjuvant radiotherapy indicated by nodal status. - Shortening the length of hospital stay - Reduction in the need for physician visits - well tolerated pain - no change in progression free survival.

Countries

Germany

Contacts

Public ContactCarl Mathis Wild

Universitätsklinikum Augsburg

mathis.wild@uk-augsburg.de0049 821 400 2331

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026